mCRPC PRO

mCRPC PRO

Charles Ryan, MD summarizes The Lancet article, Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with mCRPC: patient-reported outcome results of a randomised phase 3 trial, from November 2013.

Charles J. Ryan, MD
Professor of Clinical Medicine
Division of Hematology / Oncology
Helen Diller Family Comprehensive Cancer Center
University of California, San Francisco

Click HERE to read the abstract